GlassScriptPhysician profile
Clell W Pond
NPI 1093795510
$1,767.93
in general payments reported to CMS, 2019-2025
20 companies · $153 in 2025
The $153 reported for 2025 was more than what a typical Emergency Medical Services provider received nationally (typical 2025 total: $70.35).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $252 · 2021: $420 · 2022: $290 · 2023: $271 · 2024: $140 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $374.06 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $325.28 | 2020-2024 | Mounjaro, Zepbound |
| Abbvie INC. | $197.23 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $182.41 | 2019-2025 | Airsupra, Farxiga |
| Takeda Pharmaceuticals U.S.A., INC. | $106.02 | 2019-2022 | |
| Amgen INC. | $102.61 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.26 | 2019-2021 | |
| Abbott Laboratories | $73.97 | 2022-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $64.44 | 2020-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Genentech USA, INC. | $64.16 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.49 | 2022 | |
| Sanofi Pasteur INC. | $22.72 | 2021 | |
| Exact Sciences Corporation | $22.44 | 2023 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $18.60 | 2021 | |
| Jazz Pharmaceuticals INC. | $17.34 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17.28 | 2022 | |
| Alk-Abello, INC | $15.46 | 2024 | Ragwitek, Odactra, Grastek |
| Merck Sharp & Dohme LLC | $13.95 | 2021 | |
| Zyla Life Sciences, INC. | $12.42 | 2019 | |
| Aytu Biopharma, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clell Pond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.